Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preclinical testing for teratogenicity and developmental toxicity: methods and limitations.

P C Barrow1

  • 1MDS Pharma Services, Saint-Germain-sur-l'Asbresle, France. paul.barrow@mdsps.com

Therapie
|August 21, 2002
PubMed
Summary

Animal studies are crucial for detecting reproductive toxicity but have limitations. Monitoring human births remains essential for preventing chemical-induced birth defects, complementing animal data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive toxicity, mutagenicity and antigenicity of pamiteplase (genetical recombination).

The Journal of toxicological sciences·1997
Same author

Continuous deep intravenous infusion for use in rat pre- and postnatal studies.

Contemporary topics in laboratory animal science·1996
Same author

Continuous deep intravenous infusion in rabbit embryotoxicity studies.

Human & experimental toxicology·1996
Same author

Intravenous reproductive and developmental toxicity studies of cimadronate (YM175), a novel bisphosphonate, in rats and rabbits.

The Journal of toxicological sciences·1995
Same author

The reproductive and developmental toxicity profile of beta-cyclodextrin in rodents.

Reproductive toxicology (Elmsford, N.Y.)·1995
Same author

Differences in distribution of esterase between cell fractions of rat liver homogenates prepared in various media. Relevance to the lysosomal location of the enzyme in the intact cell.

The Biochemical journal·1971

Area of Science:

  • Toxicology
  • Developmental Biology
  • Pharmacokinetics

Background:

  • Regulatory decisions for drug approval rely heavily on animal data for reproductive and developmental toxicity.
  • Unlike other toxicities, preclinical reproductive toxicity data are not typically supplemented by human clinical trial data.
  • Animal studies have been effective in detecting reproductive toxicology for decades but are not foolproof.

Purpose of the Study:

  • To evaluate the role and limitations of animal models in assessing reproductive and developmental toxicity for drug regulation.
  • To highlight the necessity of continued research in comparative physiology and teratogenic mechanisms.
  • To emphasize the ongoing importance of human birth monitoring.

Main Methods:

  • Review of historical success and limitations of animal models in reproductive toxicology.

Related Experiment Videos

  • Discussion of advancements in developmental biology, pharmacokinetics, and comparative physiology.
  • Analysis of regulatory reliance on animal data versus human data.

    • Main Results:

    • Animal studies have a significant track record in identifying reproductive toxicants.
    • The effectiveness of animal models is contingent upon the appropriate selection of species and experimental design.
    • Limitations inherent in animal models necessitate complementary human monitoring.

    Conclusions:

    • While animal testing is invaluable for reproductive toxicology, it is not infallible.
    • Advances in related scientific fields promise more efficient animal model utilization.
    • Human birth monitoring is indispensable for the early detection and prevention of chemically induced birth defects.